Deborah Morosini
Director/Board Member at National Comprehensive Cancer Network Foundation
Profile
Deborah Morosini founded AstraZeneca Pharmaceuticals LP. She is Chief Clinical Affairs Officer & Executive VP at Prelude Therapeutics, Inc. She is also on the board of National Comprehensive Cancer Network Foundation and Clinwiki. In the past she was VP-Clinical Affairs & Patient Engagement at Loxo Oncology, Inc., VP-Clinical Affairs & Patient Engagement at Foundation Medicine, Inc. and Pathology Director at Ardais Corp. Deborah Morosini received an undergraduate degree from Mount Holyoke College, a graduate degree from New York University School of Social Work and a doctorate from Boston University School of Medicine.
Deborah Morosini active positions
Companies | Position | Start |
---|---|---|
National Comprehensive Cancer Network Foundation | Director/Board Member | - |
Clinwiki | Director/Board Member | - |
Former positions of Deborah Morosini
Companies | Position | End |
---|---|---|
PRELUDE THERAPEUTICS INCORPORATED | Chief Tech/Sci/R&D Officer | 05/04/2022 |
LOXO ONCOLOGY INC | Chief Tech/Sci/R&D Officer | 31/03/2019 |
FOUNDATION MEDICINE INC | Corporate Officer/Principal | 31/03/2016 |
Ardais Corp.
Ardais Corp. Information Technology ServicesTechnology Services Ardais Corp. provides web-based software solutions for the healthcare industry. The company is based in Lexington, MA. The company was founded by Eric B. Gordon, Alan J. Buckler, Martin Ferguson, Heidi R. Wyle. Ardais was acquired by HealthCare IT, Inc. on December 31, 2006. | Corporate Officer/Principal | - |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Founder | - |
Training of Deborah Morosini
Mount Holyoke College | Undergraduate Degree |
New York University School of Social Work | Graduate Degree |
Boston University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
Private companies | 6 |
---|---|
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
Foundation Medicine, Inc.
Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Foundation Medicine, Inc. is a molecular information company, which engages in the provision of information on clinical treatment decisions for patients with cancer. The company was founded on January 10, 2010 and is headquartered in Cambridge, MA. | Health Services |
Ardais Corp.
Ardais Corp. Information Technology ServicesTechnology Services Ardais Corp. provides web-based software solutions for the healthcare industry. The company is based in Lexington, MA. The company was founded by Eric B. Gordon, Alan J. Buckler, Martin Ferguson, Heidi R. Wyle. Ardais was acquired by HealthCare IT, Inc. on December 31, 2006. | Technology Services |
National Comprehensive Cancer Network Foundation | |
Loxo Oncology, Inc.
Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
Clinwiki |
- Stock Market
- Insiders
- Deborah Morosini